Price Charts Various Financial Sites27 Sep 2025 17:20
In June 2019 the sp was a tad above 12p. Now it's less than 1p. If we get FDA approval in a few weeks time, apart from whatever comes from the presentation at the ERS Congress starting tomorrow, then I can't see how the company could be conservatively worth less than 2 - 3 p per share and hopefully more...